Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.2B | 5.4B | 7.6B | 6.1B |
| Cost of revenue | 2.3B | 2.4B | 2.7B | 2.5B |
| Gross profit | 3.9B | 3.0B | 4.9B | 3.6B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 2.2B | 907M | 2.6B | 1.6B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 1.8B | -725M | 1.8B | 820M |
| Other income expense | -503M | -588M | 788M | 411M |
| Pretax income | -57M | 1.0B | 1.6B | 1.2B |
| Tax provision | -521M | 171M | 5M | -64M |
| Net income | 464M | 873M | 1.6B | 1.3B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 2.9B | 1.8B | 4.7B | 3.4B |
| Net income from continuing op. | 464M | 873M | 1.6B | 1.3B |
| Minority interests | 369M | 330M | 261M | 326M |
| Preferred stock dividends | — | — | — | — |